YRDCP1

Across TCGA pan-cancer cohorts, YRDCP1 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated YRDCP1 data layer.

The strongest signal is observed in kidney chromophobe (KICH), where higher YRDCP1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated YRDCP1 expression acts as an unfavorable survival marker, although some lineages such as HNSC and KIRP show a favorable association.

KICH, UVM, and MESO are the cancer types where YRDCP1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KICH	DFS	Tertile	All	0.372	0.922	<.001	75	view →
UVM	DFS	Tertile	All	0.487	0.779	.012	39	view →
MESO	OS	Tertile	III,IV	0.294	0.601	<.001	36	view →
HNSC	DFS	Tertile	All	0.784	0.674	.007	34	view →
KIRP	OS	Tertile	II,III,IV	0.923	0.670	.012	27	view →
OV	OS	Tertile	All	0.625	0.712	.018	22	view →
LUSC	OS	Tertile	II,III,IV	0.697	0.559	.028	19	view →
TGCT	DFS	Tertile	All	0.974	0.736	.002	18	view →
PRAD	OS	Quartile	All	0.966	0.997	.007	10	view →
SKCM	OS	Tertile	IV	0.415	0.861	.014	9	view →
PCPG	OS	Tertile	All	0.888	1.000	.002	9	view →
READ	OS	Median	IV	1.000	0.693	.005	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

YRDCP1–KICH (DFS)

Open the KICH breakdown →